» Articles » PMID: 17706564

The Spectrum of Neuromyelitis Optica

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2007 Aug 21
PMID 17706564
Citations 729
Authors
Affiliations
Soon will be listed here.
Abstract

Neuromyelitis optica (also known as Devic's disease) is an idiopathic, severe, demyelinating disease of the central nervous system that preferentially affects the optic nerve and spinal cord. Neuromyelitis optica has a worldwide distribution, poor prognosis, and has long been thought of as a variant of multiple sclerosis; however, clinical, laboratory, immunological, and pathological characteristics that distinguish it from multiple sclerosis are now recognised. The presence of a highly specific serum autoantibody marker (NMO-IgG) further differentiates neuromyelitis optica from multiple sclerosis and has helped to define a neuromyelitis optica spectrum of disorders. NMO-IgG reacts with the water channel aquaporin 4. Data suggest that autoantibodies to aquaporin 4 derived from peripheral B cells cause the activation of complement, inflammatory demyelination, and necrosis that is seen in neuromyelitis optica. The knowledge gained from further assessment of the exact role of NMO-IgG in the pathogenesis of neuromyelitis optica will provide a foundation for rational therapeutic trials for this rapidly disabling disease.

Citing Articles

The Percentage of Neutrophils is Independently Associated with Blood-Brain Barrier(BBB) Disruption in Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease (MOGAD).

Cheng X, Sun Y, Wang Y, Cheng W, Zhang H, Jiang Y J Inflamm Res. 2025; 18:2823-2836.

PMID: 40026312 PMC: 11871905. DOI: 10.2147/JIR.S501150.


A Case of Neuromyelitis Optica Spectrum Disorder Complicated by Posterior Reversible Encephalopathy Syndrome With Pre-existing Sjögren's Syndrome and Autoimmune Hepatitis.

Fujiwara Y, Mori N, Fukuda M, Tamaki S, Furuta A Cureus. 2025; 17(1):e78098.

PMID: 40018473 PMC: 11865253. DOI: 10.7759/cureus.78098.


A Case Report of Neuromyelitis Optica Spectrum Disorder (NMOSD) Treatment in Resource-Limited Setup: An Ethiopian Experience.

Mulate S, Molla B, Abera B, Hailemariam T, Zewde Y Clin Case Rep. 2025; 13(2):e70180.

PMID: 39926640 PMC: 11805675. DOI: 10.1002/ccr3.70180.


Efficacy of human umbilical cord mesenchymal stem cell in the treatment of neuromyelitis optica spectrum disorders: an animal study.

Xue C, Yu H, Pei X, Yao X, Ding J, Wang X Stem Cell Res Ther. 2025; 16(1):51.

PMID: 39920784 PMC: 11806600. DOI: 10.1186/s13287-025-04187-8.


χ-sepnet: Deep Neural Network for Magnetic Susceptibility Source Separation.

Kim M, Ji S, Kim J, Min K, Jeong H, Youn J Hum Brain Mapp. 2025; 46(2):e70136.

PMID: 39835664 PMC: 11748151. DOI: 10.1002/hbm.70136.